MedPage Today on MSN
Risky Drugs Still in the Mix for Dementia Patients
Questionable prescribing of CNS-active drugs persists ...
Researchers analyzed Medicare claims data to find that an estimated 25 percent of dementia patients were prescribed risky medications, including antidepressants and antipsychotics.
WHEN Stephanie Harding was first given a ‘wonder’ pain drug it seemed like the answer to her prayers. But almost a decade on, ...
Many seniors with dementia are being put at risk by brain-altering medications linked to falls, confusion and hospitalization ...
All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...
Despite longstanding guidelines, many dementia patients are still prescribed brain-altering medications that can raise the ...
Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting ...
News-Medical.Net on MSN
Research finds persistent prescribing of risky medications to older adults with dementia
Despite years of clinical guidelines warning against the practice, one in four Medicare beneficiaries with dementia is ...
After receiving a diagnosis of terminal cancer, he used his experience in public relations to draw attention to the ...
Drugmakers plan to raise U.S. prices on at least 350 branded medications in 2026, including vaccines for COVID-19 and shingles, migraine treatments, and blockbuster cancer drugs, according to data ...
American pharma giant Pfizer (PFE) leads the pack as pharmaceutical companies plan price increases for at least 350 branded medications, according to data seen by Reuters. The move underscores the ...
Every January, pharmaceutical companies increase the prices of hundreds of drugs. This year there's a disconnect between the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results